Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disorders
Identifieur interne : 000775 ( Main/Exploration ); précédent : 000774; suivant : 000776Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disorders
Auteurs : L. Kopala ; G. Smith ; A. Malla ; R. Williams ; L. Love [Canada] ; D. Talling [Canada] ; R. Balshaw [Canada]Source :
- Acta Psychiatrica Scandinavica [ 0001-690X ] ; 2006-05.
English descriptors
- KwdEn :
Abstract
Objective: To determine how the use of the newer, so called atypical antipsychotic medications, effects the pharmacoeconomic treatment burden of schizophrenia and related conditions and to provide a clear comparison of the costs and risks associated with these atypical drugs.
Url:
DOI: 10.1111/j.1600-0447.2006.00759.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000E81
- to stream Istex, to step Curation: 000E80
- to stream Istex, to step Checkpoint: 000518
- to stream Main, to step Merge: 000777
- to stream Main, to step Curation: 000775
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disorders</title><author><name sortKey="Kopala, L" sort="Kopala, L" uniqKey="Kopala L" first="L." last="Kopala">L. Kopala</name></author><author><name sortKey="Smith, G" sort="Smith, G" uniqKey="Smith G" first="G." last="Smith">G. Smith</name></author><author><name sortKey="Malla, A" sort="Malla, A" uniqKey="Malla A" first="A." last="Malla">A. Malla</name></author><author><name sortKey="Williams, R" sort="Williams, R" uniqKey="Williams R" first="R." last="Williams">R. Williams</name></author><author><name sortKey="Love, L" sort="Love, L" uniqKey="Love L" first="L." last="Love">L. Love</name></author><author><name sortKey="Talling, D" sort="Talling, D" uniqKey="Talling D" first="D." last="Talling">D. Talling</name></author><author><name sortKey="Balshaw, R" sort="Balshaw, R" uniqKey="Balshaw R" first="R." last="Balshaw">R. Balshaw</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D24658C742A85B8FD5206E56BC290F5AFB33AD35</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1111/j.1600-0447.2006.00759.x</idno><idno type="url">https://api.istex.fr/document/D24658C742A85B8FD5206E56BC290F5AFB33AD35/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000E81</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000E81</idno><idno type="wicri:Area/Istex/Curation">000E80</idno><idno type="wicri:Area/Istex/Checkpoint">000518</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000518</idno><idno type="wicri:doubleKey">0001-690X:2006:Kopala L:resource:utilization:in</idno><idno type="wicri:Area/Main/Merge">000777</idno><idno type="wicri:Area/Main/Curation">000775</idno><idno type="wicri:Area/Main/Exploration">000775</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disorders</title><author><name sortKey="Kopala, L" sort="Kopala, L" uniqKey="Kopala L" first="L." last="Kopala">L. Kopala</name><affiliation><wicri:noCountry code="subField">BC</wicri:noCountry></affiliation></author><author><name sortKey="Smith, G" sort="Smith, G" uniqKey="Smith G" first="G." last="Smith">G. Smith</name><affiliation><wicri:noCountry code="subField">BC</wicri:noCountry></affiliation></author><author><name sortKey="Malla, A" sort="Malla, A" uniqKey="Malla A" first="A." last="Malla">A. Malla</name><affiliation><wicri:noCountry code="subField">QC</wicri:noCountry></affiliation></author><author><name sortKey="Williams, R" sort="Williams, R" uniqKey="Williams R" first="R." last="Williams">R. Williams</name><affiliation><wicri:noCountry code="subField">BC</wicri:noCountry></affiliation></author><author><name sortKey="Love, L" sort="Love, L" uniqKey="Love L" first="L." last="Love">L. Love</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Syreon Corporation, Vancouver, BC</wicri:regionArea><wicri:noRegion>BC</wicri:noRegion></affiliation></author><author><name sortKey="Talling, D" sort="Talling, D" uniqKey="Talling D" first="D." last="Talling">D. Talling</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Syreon Corporation, Vancouver, BC</wicri:regionArea><wicri:noRegion>BC</wicri:noRegion></affiliation></author><author><name sortKey="Balshaw, R" sort="Balshaw, R" uniqKey="Balshaw R" first="R." last="Balshaw">R. Balshaw</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Syreon Corporation, Vancouver, BC</wicri:regionArea><wicri:noRegion>BC</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Acta Psychiatrica Scandinavica</title><idno type="ISSN">0001-690X</idno><idno type="eISSN">1600-0447</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2006-05">2006-05</date><biblScope unit="volume">113</biblScope><biblScope unit="supplement">s430</biblScope><biblScope unit="page" from="29">29</biblScope><biblScope unit="page" to="39">39</biblScope></imprint><idno type="ISSN">0001-690X</idno></series><idno type="istex">D24658C742A85B8FD5206E56BC290F5AFB33AD35</idno><idno type="DOI">10.1111/j.1600-0447.2006.00759.x</idno><idno type="ArticleID">ACPS759</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0001-690X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>cost analysis</term><term>prognosis</term><term>schizophrenia</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Objective: To determine how the use of the newer, so called atypical antipsychotic medications, effects the pharmacoeconomic treatment burden of schizophrenia and related conditions and to provide a clear comparison of the costs and risks associated with these atypical drugs.</div></front></TEI><affiliations><list><country><li>Canada</li></country></list><tree><noCountry><name sortKey="Kopala, L" sort="Kopala, L" uniqKey="Kopala L" first="L." last="Kopala">L. Kopala</name><name sortKey="Malla, A" sort="Malla, A" uniqKey="Malla A" first="A." last="Malla">A. Malla</name><name sortKey="Smith, G" sort="Smith, G" uniqKey="Smith G" first="G." last="Smith">G. Smith</name><name sortKey="Williams, R" sort="Williams, R" uniqKey="Williams R" first="R." last="Williams">R. Williams</name></noCountry><country name="Canada"><noRegion><name sortKey="Love, L" sort="Love, L" uniqKey="Love L" first="L." last="Love">L. Love</name></noRegion><name sortKey="Balshaw, R" sort="Balshaw, R" uniqKey="Balshaw R" first="R." last="Balshaw">R. Balshaw</name><name sortKey="Talling, D" sort="Talling, D" uniqKey="Talling D" first="D." last="Talling">D. Talling</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/TherFamFrancoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000775 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000775 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Psychologie
|area= TherFamFrancoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:D24658C742A85B8FD5206E56BC290F5AFB33AD35
|texte= Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disorders
}}
| This area was generated with Dilib version V0.6.29. |  |